Donate Now
  • What We're Working On
Impact of arthritis medications on the mother and child during pregnancy and beyond
FAMILY-Study_PLS-image
Scientific Study Title:
Following maternal, neonatal, and childhood outcomes associated with use of arthritis medications perinatally (FAMILY)
Start Date:
  • 2023
End Date:
  • 2026
Research Category
Tags

Why do this research?

Different types of arthritis strike people during their childbearing years. We have some information about the effects of arthritis medications on the baby, however, less data exists on the impacts later in childhood and on the person with arthritis who gave birth. We know even less about ways that newer drugs, such as biosimilars are being used during pregnancy and their impacts on the mother and child after giving birth.

What will be done?

State-of-the-art statistical methods will use “big data” to analyze British Columbia healthcare records of those women who are pregnant and have arthritis. The use of arthritis medications during pregnancy will be correlated to the health of birthing parents and their children. This will inform future treatment decisions for women with arthritis in their childbearing years.

The Research Team

Principal Investigator

  • Dr. Mary De Vera, PhD, Senior Scientist, Arthritis Research Canada (University of British Columbia)

Co-Investigators

  • Neda Amiri, BSc, MD, MHSC, FRCPC Clinician Investigator, Arthritis Research Canada (University of British Columbia)
  • Corisande Baldwin, MD, FRCPC, Adult Rheumatologist, Victoria BC
  • Stephanie Ensworth (University of British Columbia)
  • Eric C Sayre, PhD
  • Laura Schummers (University of British Columbia)
  • Nevena Rebic , BSc (Pharm), MSc (Pharm) Candidate, Arthritis Research Canada Trainee (University of British Columbia)

How Can People Get Involved?

This study will be completed using Administrative Health Data.

The project will use data that is already collected so there is no participant recruitment.

Media and Infographics

Related Research

What We're Working On Right Now

Exploring a New Immune Cell Therapy for People with Autoimmune Diseases

Systemic sclerosis and systemic lupus erythematosus are serious autoimmune diseases that can cause damage to many organs including the skin, lungs and kidneys. In this project, we will study a new type of treatment that may better control these diseases by targeting the immune cells that cause them. If successful, it could reduce inflammation, slow or stop disease progression, and may even help reset the immune system, so that some patients no longer need long-term immune-suppressing medications.
Read More

Understanding how scleroderma affects people over time

People living with scleroderma experience challenges such as pain, disability, and mental health concerns, but we still don’t know much about how these problems change over time or why some people do better than others. For this research project, our goal is to improve our understanding of how scleroderma affects people’s daily lives and identify factors that may predict changes in their health.
Read More

How can we help Canadians age at home to improve health outcomes and support a sustainable healthcare system?

As Canada’s population ages, home care is important for helping older adults remain safely within their homes. Our research team is linking data from the Canadian Longitudinal Study on Aging with health records in British Columbia, Ontario, and New Brunswick, to track patterns of paid and unpaid home care use over time.
Read More